Non-invasive diagnosis for nephrotic syndrome
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a non-invasive approach to diagnose idiopathic nephrotic syndrome, which affects the kidneys. It may help patients avoid a kidney biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are currently hospitalized for a first episode of nephrotic syndrome (high protein in urine and low albumin in blood)
- You do not have anti-PLA2r antibodies in your blood
- Your doctor has decided you need a kidney biopsy for diagnosis
- You do not have known lupus or IgA nephropathy before this episode
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments (albumin and fresh frozen plasma) to see which is better for reducing swelling in children with nephrotic syndrome when water pills alone don't work. The goal is to find a safer and more effective way to manage this difficult-to-treat swelling.
This study looks at children newly diagnosed with nephrotic syndrome to understand how genes and proteins in the blood might predict the disease's course and response to treatment. By collecting samples, researchers hope to find markers that could guide better, more personalized care for future patients.
This study looks for specific proteins (autoantibodies) in your blood that may be linked to certain kidney diseases. It aims to better understand the immune system's role in minimal change disease and FSGS, which could lead to better treatments.
This study looks at a blood test for a protein called RNASE1 to see if it can help identify kidney problems in people with lupus. It may help doctors diagnose and monitor lupus nephritis more easily.
This Phase 2 trial studies AP1189 in people with a specific immune-related kidney disease called iMN and very high urine protein. It aims to see whether the drug is safe and tolerable and if it can reduce protein in the urine.
This trial looks at how immune cells and gut (microbiota) changes relate to nephrotic syndrome flare-ups, and how a treatment approach may help during active attacks. You may be able to take part if you’re currently having a flare with high protein in your urine and meet key safety rules.
Hear when a new Idiopathic Nephrotic Syndrome (INS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.